Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disease
in which the pathological substrate is a fibro-fatty replacement of the right ventricular myocardium.
The major clinical features are different types of arrhythmias with a left branch block pattern.
ARVC shows autosomal dominant inheritance with incomplete penetrance. Recessive forms
were also described, although in association with skin disorders.
Ten genetic loci have been discovered so far and mutations were reported in five different genes.
ARVD1 was associated with regulatory mutations of transforming growth factor beta-3 (TGFβ3),
whereas ARVD2, characterized by effort-induced polymorphic arrhythmias, was associated with
mutations in cardiac ryanodine receptor-2 (RYR2). All other mutations identified to date have
been detected in genes encoding desmosomal proteins: plakoglobin (JUP) which causes Naxos
disease (a recessive form of ARVC associated with palmoplantar keratosis and woolly hair);
desmoplakin (DSP) which causes the autosomal dominant ARVD8 and plakophilin-2 (PKP2) involved
in ARVD9. Desmosomes are important cell-to-cell adhesion junctions predominantly
found in epidermis and heart; they are believed to couple cytoskeletal elements to plasma membrane
in cell-to-cell or cell-to-substrate adhesions. (Heart International 2006; 2: 17-26)
Arrhythmias, Sudden death, Molecular genetics, Desmosomes
Alessandra Rampazzo, Dipartimento di Biologia, Università degli Studi di Padova, Via Ugo Bassi, 58/B, 35131 Padova – Italy, alessandra.rampazzo@unipd.it
The financial support for this study was NIH grant
U04HL65652 and ARVD Project QLGI-CT-2000-01091,UE.
Trending Topic
Catheter ablation (CA) is an invasive adjunctive therapeutic option for atrial and ventricular arrhythmias, in uncontrolled cases, following optimal medical therapy.1,2 The validation of 3D mapping and its implementation into clinical usage has been a remarkable achievement in the field of complex ablation of scar-related ventricular tachycardia (VT) in the early 2000s.3 In the setting of atrial […]
Welcome to the latest issue of the European Journal of Arrhythmia & Electrophysiology, the official journal of the Arrhythmia Alliance. We are honoured to present a series of compelling articles that reflect cutting-edge developments and diverse perspectives in this ever-evolving ...
Ventricular tachycardia (VT) ablation presents a challenging and growing area of focus in the realm of complex ablation, with promises of improved patient’s quality of life and clinical outcomes.1,2 Classic approaches to VT ablation centered on arrhythmia induction and ...
For decades, right ventricular pacing (RVP) has been the leading pacing technique and has been proven to be effective in treating patients with symptomatic bradycardia. However, dyssynchrony caused by non-physiological ventricular activation results in pacing-induced cardiomyopathy occurs in approximately 15% of ...
Supraventricular tachycardia (SVT) is an important cause of intrusive palpitation symptoms. This expert interview explores a nurse-led end-to-end pathway for the diagnosis, assessment and management of this condition. It was conducted at the Barts Heart Centre of Barts Health NHS ...
Highlights Failure to target and deliver durable radiofrequency lesions to all functionally critical areas has been identified as an important cause of ventricular tachycardia recurrence and is particularly challenging in deep midmyocardial or very extensive substrate where point-by-point radiofrequency ablation ...
Bradycardia, renal failure, atrioventricular nodal blockade, shock and hyperkalemia (BRASH) syndrome is a rare, often unrecognized but potentially life-threatening clinical entity that is characterized by the pentad of symptoms after which it is named. BRASH syndrome is seen most commonly ...
Radiofrequency (RF) ablation involves delivering medium-to-high-frequency alternating current, which is electrically conducted to cardiac tissue that constitutes a part of the circuit. The unipolar circuitry contains the generator, transmission lines, catheter, cardiac tissue, interposed tissue and dispersive electrode (ground pad/...
Several smart, connected and direct-to-consumer wearable devices capable of detecting cardiac arrhythmias have proliferated in the marketplace in the last decade. Increasingly, these devices are being marketed as “medical grade” in addition to “wellness” devices.1 New iterations of smartwatch and ...
Introduction: With the ever-increasing importance of home monitoring for the follow-up of cardiac implanted electronic devices (CIED), emphasised during the COVID pandemic, the workload for CIED follow-up clinics has grown exponentially. The demand on services is exceeding resource, with innovative ...
Welcome to a new issue of the European Journal of Arrhythmia & Electrophysiology. As the ongoing coronavirus disease 2019 (COVID-19) pandemic continues to provide unprecedented challenges for electrophysiologists and other healthcare providers who manage arrhythmias, we hope you find these topical ...
The current outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has developed into a worldwide pandemic affecting millions of lives in one way or another.1 Over the period of 1 year since the disease was first ...
Paroxysmal supraventricular tachycardia (PSVT) defines a group of cardiac arrhythmias where the underlying mechanism is dependent upon structures at or above the level of the atrioventricular node. The recent PRE-EMPT study retrospectively evaluated health records of over 4.2 million people in ...
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.